首页 | 官方网站   微博 | 高级检索  
     


Design of hemocompatible poly(DMAEMA‐co‐PEGMA) hydrogels for controlled release of insulin
Authors:Lemmuel L Tayo  Antoine Venault  Vryan Gil R Constantino  Alvin R Caparanga  Arunachalam Chinnathambi  Sulaiman Ali Alharbi  Jie Zheng  Yung Chang
Affiliation:1. R&D Center for Membrane Technology, Department of Chemical Engineering, Chung Yuan Christian University, Chung‐Li, Taoyuan, Taiwan;2. School of Chemical Engineering and Chemistry, Mapúa Institute of Technology, Intramuros, Manila, Philippines;3. Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia;4. Department of Chemical and Biomolecular Engineering, University of Akron, Akron, OH
Abstract:This works aims at (i) studying the antiadhesive properties and the hemocompatibility of poly2‐(dimethylamino)ethyl methacrylate]‐co‐poly(ethylene glycol)methacrylate] poly(DMAEMA‐co‐PEGMA)] copolymers and (ii) investigating the insulin delivery kinetics through hydrogels at physiological pH. A series of poly(DMAEMA‐co‐PEGMA) hydrogels have been synthesized, and their controlled composition was confirmed by X‐ray photoelectron spectroscopy. Then, antibiofouling properties of hydrogels—fibrinogen, erythrocytes, and thrombocytes adhesion—are correlated to their molecular compositions through their hydrophilic properties. As DMAEMA/PEGMA ratio of 70/30 (D70) offers the best compromise between pH sensitivity and hemocompatibility, it is selected for investigating the kinetic rate of insulin release at physiological pH, and the diffusion coefficient of insulin in gel is found to be 0.64 × 10?7 cm2 s?1. Overall, this study unveils that poly(DMAEMA‐co‐PEGMA) copolymers are promising hemocompatible materials for drug delivery systems. © 2015 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2015 , 132, 42365.
Keywords:biocompatibility  biomedical applications  biomaterials  copolymers  gels
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号